nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—Azelaic Acid—TYR—skin cancer	0.0203	1	CrCbGaD
Vorinostat—Squamous cell carcinoma—Vemurafenib—skin cancer	0.0201	0.0608	CcSEcCtD
Vorinostat—HDAC1—manus—skin cancer	0.0195	0.0623	CbGeAlD
Vorinostat—HDAC1—manual digit—skin cancer	0.019	0.0609	CbGeAlD
Vorinostat—Squamous cell carcinoma—Imiquimod—skin cancer	0.0171	0.0519	CcSEcCtD
Vorinostat—NCOR1—hair follicle—skin cancer	0.0145	0.0464	CbGeAlD
Vorinostat—HDAC3—hair follicle—skin cancer	0.0127	0.0407	CbGeAlD
Vorinostat—HDAC1—hair follicle—skin cancer	0.0116	0.0373	CbGeAlD
Vorinostat—NCOR1—neck—skin cancer	0.00973	0.0311	CbGeAlD
Vorinostat—Neoplasm malignant—Vismodegib—skin cancer	0.00864	0.0262	CcSEcCtD
Vorinostat—HDAC3—nipple—skin cancer	0.00862	0.0276	CbGeAlD
Vorinostat—HDAC1—nipple—skin cancer	0.0079	0.0253	CbGeAlD
Vorinostat—HDAC1—neck—skin cancer	0.00781	0.025	CbGeAlD
Vorinostat—NCOR1—connective tissue—skin cancer	0.00697	0.0223	CbGeAlD
Vorinostat—HDAC6—female reproductive system—skin cancer	0.00655	0.021	CbGeAlD
Vorinostat—NCOR1—skin of body—skin cancer	0.0063	0.0202	CbGeAlD
Vorinostat—HDAC3—connective tissue—skin cancer	0.00611	0.0196	CbGeAlD
Vorinostat—HDAC11—mammalian vulva—skin cancer	0.00592	0.019	CbGeAlD
Vorinostat—Myelosuppression—Bleomycin—skin cancer	0.00589	0.0178	CcSEcCtD
Vorinostat—HDAC2—hair follicle—skin cancer	0.00586	0.0187	CbGeAlD
Vorinostat—HDAC8—female reproductive system—skin cancer	0.00581	0.0186	CbGeAlD
Vorinostat—HDAC4—female reproductive system—skin cancer	0.00565	0.0181	CbGeAlD
Vorinostat—HDAC1—connective tissue—skin cancer	0.0056	0.0179	CbGeAlD
Vorinostat—HDAC3—skin of body—skin cancer	0.00552	0.0177	CbGeAlD
Vorinostat—Myelosuppression—Dactinomycin—skin cancer	0.0055	0.0166	CcSEcCtD
Vorinostat—HDAC6—head—skin cancer	0.00548	0.0175	CbGeAlD
Vorinostat—Neoplasm malignant—Vemurafenib—skin cancer	0.00534	0.0162	CcSEcCtD
Vorinostat—HDAC1—epithelium—skin cancer	0.00532	0.017	CbGeAlD
Vorinostat—HDAC11—lymphoid tissue—skin cancer	0.00526	0.0168	CbGeAlD
Vorinostat—NCOR1—lymphoid tissue—skin cancer	0.0051	0.0163	CbGeAlD
Vorinostat—HDAC11—female reproductive system—skin cancer	0.00507	0.0162	CbGeAlD
Vorinostat—HDAC1—skin of body—skin cancer	0.00506	0.0162	CbGeAlD
Vorinostat—HDAC3—mammalian vulva—skin cancer	0.00503	0.0161	CbGeAlD
Vorinostat—Dehydration—Vismodegib—skin cancer	0.00498	0.0151	CcSEcCtD
Vorinostat—Myelosuppression—Temozolomide—skin cancer	0.00497	0.015	CcSEcCtD
Vorinostat—NCOR1—female reproductive system—skin cancer	0.00492	0.0157	CbGeAlD
Vorinostat—Hypokalaemia—Vismodegib—skin cancer	0.00488	0.0148	CcSEcCtD
Vorinostat—HDAC4—head—skin cancer	0.00472	0.0151	CbGeAlD
Vorinostat—NR0B1—female reproductive system—skin cancer	0.00462	0.0148	CbGeAlD
Vorinostat—HDAC1—mammalian vulva—skin cancer	0.00461	0.0148	CbGeAlD
Vorinostat—Myelosuppression—Fluorouracil—skin cancer	0.00458	0.0139	CcSEcCtD
Vorinostat—HDAC3—lymphoid tissue—skin cancer	0.00447	0.0143	CbGeAlD
Vorinostat—Proteinuria—Imiquimod—skin cancer	0.00443	0.0134	CcSEcCtD
Vorinostat—Protein urine present—Imiquimod—skin cancer	0.00436	0.0132	CcSEcCtD
Vorinostat—HDAC3—female reproductive system—skin cancer	0.00431	0.0138	CbGeAlD
Vorinostat—HDAC11—head—skin cancer	0.00424	0.0136	CbGeAlD
Vorinostat—Weight decreased—Vismodegib—skin cancer	0.00419	0.0127	CcSEcCtD
Vorinostat—NCOR1—head—skin cancer	0.00411	0.0132	CbGeAlD
Vorinostat—HDAC1—lymphoid tissue—skin cancer	0.00409	0.0131	CbGeAlD
Vorinostat—HDAC9—lymphoid tissue—skin cancer	0.00403	0.0129	CbGeAlD
Vorinostat—HDAC1—female reproductive system—skin cancer	0.00395	0.0126	CbGeAlD
Vorinostat—HDAC2—neck—skin cancer	0.00393	0.0126	CbGeAlD
Vorinostat—HDAC9—female reproductive system—skin cancer	0.00388	0.0124	CbGeAlD
Vorinostat—HDAC6—lymph node—skin cancer	0.00383	0.0123	CbGeAlD
Vorinostat—Deep vein thrombosis—Temozolomide—skin cancer	0.00383	0.0116	CcSEcCtD
Vorinostat—Gastrointestinal symptom NOS—Fluorouracil—skin cancer	0.00365	0.0111	CcSEcCtD
Vorinostat—Embolism—Temozolomide—skin cancer	0.00363	0.011	CcSEcCtD
Vorinostat—HDAC3—head—skin cancer	0.0036	0.0115	CbGeAlD
Vorinostat—HDAC8—lymph node—skin cancer	0.0034	0.0109	CbGeAlD
Vorinostat—Myelosuppression—Docetaxel—skin cancer	0.00331	0.01	CcSEcCtD
Vorinostat—HDAC4—lymph node—skin cancer	0.0033	0.0106	CbGeAlD
Vorinostat—HDAC1—head—skin cancer	0.0033	0.0106	CbGeAlD
Vorinostat—Alopecia—Vismodegib—skin cancer	0.00328	0.00992	CcSEcCtD
Vorinostat—HDAC9—head—skin cancer	0.00324	0.0104	CbGeAlD
Vorinostat—Dysgeusia—Vismodegib—skin cancer	0.00316	0.00957	CcSEcCtD
Vorinostat—Muscle spasms—Vismodegib—skin cancer	0.0031	0.00939	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Imiquimod—skin cancer	0.00299	0.00906	CcSEcCtD
Vorinostat—HDAC11—lymph node—skin cancer	0.00297	0.00949	CbGeAlD
Vorinostat—Lethargy—Imiquimod—skin cancer	0.00288	0.00872	CcSEcCtD
Vorinostat—NCOR1—lymph node—skin cancer	0.00288	0.00921	CbGeAlD
Vorinostat—HDAC2—connective tissue—skin cancer	0.00282	0.00901	CbGeAlD
Vorinostat—HDAC2—epithelium—skin cancer	0.00267	0.00856	CbGeAlD
Vorinostat—Weight decreased—Vemurafenib—skin cancer	0.00259	0.00784	CcSEcCtD
Vorinostat—Deep vein thrombosis—Docetaxel—skin cancer	0.00255	0.00771	CcSEcCtD
Vorinostat—HDAC2—skin of body—skin cancer	0.00254	0.00814	CbGeAlD
Vorinostat—HDAC3—lymph node—skin cancer	0.00252	0.00807	CbGeAlD
Vorinostat—Embolism—Docetaxel—skin cancer	0.00241	0.00731	CcSEcCtD
Vorinostat—Pulmonary embolism—Temozolomide—skin cancer	0.00233	0.00706	CcSEcCtD
Vorinostat—Pancytopenia—Imiquimod—skin cancer	0.00232	0.00702	CcSEcCtD
Vorinostat—HDAC1—lymph node—skin cancer	0.00231	0.00739	CbGeAlD
Vorinostat—Decreased appetite—Vismodegib—skin cancer	0.00229	0.00693	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Vismodegib—skin cancer	0.00227	0.00688	CcSEcCtD
Vorinostat—HDAC9—lymph node—skin cancer	0.00227	0.00727	CbGeAlD
Vorinostat—Fatigue—Vismodegib—skin cancer	0.00227	0.00687	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Imiquimod—skin cancer	0.00227	0.00687	CcSEcCtD
Vorinostat—Oedema peripheral—Vemurafenib—skin cancer	0.00226	0.00683	CcSEcCtD
Vorinostat—Constipation—Vismodegib—skin cancer	0.00225	0.00682	CcSEcCtD
Vorinostat—Sepsis—Dactinomycin—skin cancer	0.00224	0.00677	CcSEcCtD
Vorinostat—Acute coronary syndrome—Imiquimod—skin cancer	0.00214	0.00649	CcSEcCtD
Vorinostat—Myocardial infarction—Imiquimod—skin cancer	0.00213	0.00646	CcSEcCtD
Vorinostat—HDAC2—lymphoid tissue—skin cancer	0.00206	0.00659	CbGeAlD
Vorinostat—Chills—Vemurafenib—skin cancer	0.00205	0.00622	CcSEcCtD
Vorinostat—Alopecia—Vemurafenib—skin cancer	0.00202	0.00613	CcSEcCtD
Vorinostat—HDAC2—female reproductive system—skin cancer	0.00199	0.00636	CbGeAlD
Vorinostat—Dysgeusia—Vemurafenib—skin cancer	0.00195	0.00591	CcSEcCtD
Vorinostat—Lethargy—Dactinomycin—skin cancer	0.00191	0.00578	CcSEcCtD
Vorinostat—Asthenia—Vismodegib—skin cancer	0.00189	0.00572	CcSEcCtD
Vorinostat—Sepsis—Fluorouracil—skin cancer	0.00186	0.00564	CcSEcCtD
Vorinostat—Pruritus—Vismodegib—skin cancer	0.00186	0.00564	CcSEcCtD
Vorinostat—Diarrhoea—Vismodegib—skin cancer	0.0018	0.00546	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Temozolomide—skin cancer	0.00179	0.00543	CcSEcCtD
Vorinostat—Chills—Imiquimod—skin cancer	0.00175	0.00531	CcSEcCtD
Vorinostat—Cough—Vemurafenib—skin cancer	0.00174	0.00527	CcSEcCtD
Vorinostat—Alopecia—Imiquimod—skin cancer	0.00173	0.00523	CcSEcCtD
Vorinostat—Vomiting—Vismodegib—skin cancer	0.00167	0.00507	CcSEcCtD
Vorinostat—HDAC2—head—skin cancer	0.00166	0.00531	CbGeAlD
Vorinostat—Pancytopenia—Bleomycin—skin cancer	0.00165	0.00498	CcSEcCtD
Vorinostat—Infection—Vemurafenib—skin cancer	0.00162	0.00489	CcSEcCtD
Vorinostat—Lethargy—Fluorouracil—skin cancer	0.00159	0.00482	CcSEcCtD
Vorinostat—Dehydration—Temozolomide—skin cancer	0.00157	0.00476	CcSEcCtD
Vorinostat—Weight decreased—Bleomycin—skin cancer	0.00157	0.00475	CcSEcCtD
Vorinostat—Nausea—Vismodegib—skin cancer	0.00156	0.00474	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00156	0.00472	CcSEcCtD
Vorinostat—Angioedema—Imiquimod—skin cancer	0.00155	0.0047	CcSEcCtD
Vorinostat—Pulmonary embolism—Docetaxel—skin cancer	0.00155	0.00469	CcSEcCtD
Vorinostat—Hypokalaemia—Temozolomide—skin cancer	0.00154	0.00466	CcSEcCtD
Vorinostat—Pancytopenia—Dactinomycin—skin cancer	0.00154	0.00465	CcSEcCtD
Vorinostat—Syncope—Imiquimod—skin cancer	0.00152	0.00462	CcSEcCtD
Vorinostat—Acute coronary syndrome—Bleomycin—skin cancer	0.00152	0.00461	CcSEcCtD
Vorinostat—Myocardial infarction—Bleomycin—skin cancer	0.00151	0.00459	CcSEcCtD
Vorinostat—Neutropenia—Dactinomycin—skin cancer	0.00151	0.00458	CcSEcCtD
Vorinostat—Loss of consciousness—Imiquimod—skin cancer	0.00149	0.00452	CcSEcCtD
Vorinostat—Cough—Imiquimod—skin cancer	0.00148	0.00449	CcSEcCtD
Vorinostat—Chest pain—Imiquimod—skin cancer	0.00145	0.00438	CcSEcCtD
Vorinostat—Dry mouth—Imiquimod—skin cancer	0.00142	0.00429	CcSEcCtD
Vorinostat—Decreased appetite—Vemurafenib—skin cancer	0.00141	0.00428	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Vemurafenib—skin cancer	0.0014	0.00425	CcSEcCtD
Vorinostat—Fatigue—Vemurafenib—skin cancer	0.0014	0.00425	CcSEcCtD
Vorinostat—Constipation—Vemurafenib—skin cancer	0.00139	0.00421	CcSEcCtD
Vorinostat—Pancytopenia—Temozolomide—skin cancer	0.00139	0.0042	CcSEcCtD
Vorinostat—Infection—Imiquimod—skin cancer	0.00138	0.00417	CcSEcCtD
Vorinostat—Neutropenia—Temozolomide—skin cancer	0.00137	0.00414	CcSEcCtD
Vorinostat—Shock—Imiquimod—skin cancer	0.00137	0.00413	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Temozolomide—skin cancer	0.00136	0.00411	CcSEcCtD
Vorinostat—Sepsis—Docetaxel—skin cancer	0.00134	0.00407	CcSEcCtD
Vorinostat—Weight decreased—Temozolomide—skin cancer	0.00132	0.00401	CcSEcCtD
Vorinostat—Anorexia—Imiquimod—skin cancer	0.00132	0.004	CcSEcCtD
Vorinostat—Hyperglycaemia—Temozolomide—skin cancer	0.00132	0.00399	CcSEcCtD
Vorinostat—Body temperature increased—Vemurafenib—skin cancer	0.00129	0.00389	CcSEcCtD
Vorinostat—Pancytopenia—Fluorouracil—skin cancer	0.00128	0.00387	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00125	0.00379	CcSEcCtD
Vorinostat—Chills—Bleomycin—skin cancer	0.00124	0.00377	CcSEcCtD
Vorinostat—Alopecia—Bleomycin—skin cancer	0.00123	0.00371	CcSEcCtD
Vorinostat—Decreased appetite—Imiquimod—skin cancer	0.00121	0.00365	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Imiquimod—skin cancer	0.0012	0.00363	CcSEcCtD
Vorinostat—Fatigue—Imiquimod—skin cancer	0.0012	0.00362	CcSEcCtD
Vorinostat—Acute coronary syndrome—Fluorouracil—skin cancer	0.00118	0.00359	CcSEcCtD
Vorinostat—Myocardial infarction—Fluorouracil—skin cancer	0.00118	0.00357	CcSEcCtD
Vorinostat—Asthenia—Vemurafenib—skin cancer	0.00117	0.00353	CcSEcCtD
Vorinostat—HDAC2—lymph node—skin cancer	0.00116	0.00372	CbGeAlD
Vorinostat—Chills—Dactinomycin—skin cancer	0.00116	0.00352	CcSEcCtD
Vorinostat—Oedema peripheral—Temozolomide—skin cancer	0.00115	0.00349	CcSEcCtD
Vorinostat—Pruritus—Vemurafenib—skin cancer	0.00115	0.00349	CcSEcCtD
Vorinostat—Lethargy—Docetaxel—skin cancer	0.00115	0.00348	CcSEcCtD
Vorinostat—Alopecia—Dactinomycin—skin cancer	0.00114	0.00346	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00113	0.00341	CcSEcCtD
Vorinostat—Anaemia—Bleomycin—skin cancer	0.00112	0.00338	CcSEcCtD
Vorinostat—Diarrhoea—Vemurafenib—skin cancer	0.00111	0.00337	CcSEcCtD
Vorinostat—Body temperature increased—Imiquimod—skin cancer	0.0011	0.00332	CcSEcCtD
Vorinostat—Leukopenia—Bleomycin—skin cancer	0.00108	0.00327	CcSEcCtD
Vorinostat—Dizziness—Vemurafenib—skin cancer	0.00108	0.00326	CcSEcCtD
Vorinostat—Cough—Bleomycin—skin cancer	0.00105	0.00319	CcSEcCtD
Vorinostat—Chills—Temozolomide—skin cancer	0.00105	0.00318	CcSEcCtD
Vorinostat—Dehydration—Docetaxel—skin cancer	0.00105	0.00317	CcSEcCtD
Vorinostat—Anaemia—Dactinomycin—skin cancer	0.00104	0.00315	CcSEcCtD
Vorinostat—Vomiting—Vemurafenib—skin cancer	0.00103	0.00313	CcSEcCtD
Vorinostat—Alopecia—Temozolomide—skin cancer	0.00103	0.00313	CcSEcCtD
Vorinostat—Chest pain—Bleomycin—skin cancer	0.00103	0.00311	CcSEcCtD
Vorinostat—Headache—Vemurafenib—skin cancer	0.00102	0.00309	CcSEcCtD
Vorinostat—Leukopenia—Dactinomycin—skin cancer	0.00101	0.00305	CcSEcCtD
Vorinostat—Dysgeusia—Temozolomide—skin cancer	0.000998	0.00302	CcSEcCtD
Vorinostat—Asthenia—Imiquimod—skin cancer	0.000996	0.00301	CcSEcCtD
Vorinostat—Pruritus—Imiquimod—skin cancer	0.000982	0.00297	CcSEcCtD
Vorinostat—Infection—Bleomycin—skin cancer	0.000979	0.00297	CcSEcCtD
Vorinostat—Nausea—Vemurafenib—skin cancer	0.000966	0.00293	CcSEcCtD
Vorinostat—Thrombocytopenia—Bleomycin—skin cancer	0.000965	0.00292	CcSEcCtD
Vorinostat—Alopecia—Fluorouracil—skin cancer	0.000953	0.00289	CcSEcCtD
Vorinostat—Diarrhoea—Imiquimod—skin cancer	0.000949	0.00287	CcSEcCtD
Vorinostat—Anaemia—Temozolomide—skin cancer	0.000942	0.00285	CcSEcCtD
Vorinostat—Anorexia—Bleomycin—skin cancer	0.00094	0.00284	CcSEcCtD
Vorinostat—Angioedema—Temozolomide—skin cancer	0.000931	0.00282	CcSEcCtD
Vorinostat—Pancytopenia—Docetaxel—skin cancer	0.000923	0.0028	CcSEcCtD
Vorinostat—Dizziness—Imiquimod—skin cancer	0.000918	0.00278	CcSEcCtD
Vorinostat—Infection—Dactinomycin—skin cancer	0.000913	0.00277	CcSEcCtD
Vorinostat—Leukopenia—Temozolomide—skin cancer	0.000912	0.00276	CcSEcCtD
Vorinostat—Neutropenia—Docetaxel—skin cancer	0.000909	0.00275	CcSEcCtD
Vorinostat—Thrombocytopenia—Dactinomycin—skin cancer	0.0009	0.00273	CcSEcCtD
Vorinostat—Cough—Temozolomide—skin cancer	0.000889	0.00269	CcSEcCtD
Vorinostat—Vomiting—Imiquimod—skin cancer	0.000882	0.00267	CcSEcCtD
Vorinostat—Weight decreased—Docetaxel—skin cancer	0.00088	0.00266	CcSEcCtD
Vorinostat—Anorexia—Dactinomycin—skin cancer	0.000876	0.00265	CcSEcCtD
Vorinostat—Headache—Imiquimod—skin cancer	0.000869	0.00263	CcSEcCtD
Vorinostat—Anaemia—Fluorouracil—skin cancer	0.000868	0.00263	CcSEcCtD
Vorinostat—Decreased appetite—Bleomycin—skin cancer	0.000857	0.00259	CcSEcCtD
Vorinostat—Acute coronary syndrome—Docetaxel—skin cancer	0.000855	0.00259	CcSEcCtD
Vorinostat—Myocardial infarction—Docetaxel—skin cancer	0.00085	0.00257	CcSEcCtD
Vorinostat—Dry mouth—Temozolomide—skin cancer	0.000848	0.00257	CcSEcCtD
Vorinostat—Leukopenia—Fluorouracil—skin cancer	0.00084	0.00254	CcSEcCtD
Vorinostat—Infection—Temozolomide—skin cancer	0.000826	0.0025	CcSEcCtD
Vorinostat—Nausea—Imiquimod—skin cancer	0.000824	0.0025	CcSEcCtD
Vorinostat—Thrombocytopenia—Temozolomide—skin cancer	0.000814	0.00246	CcSEcCtD
Vorinostat—Chest pain—Fluorouracil—skin cancer	0.000799	0.00242	CcSEcCtD
Vorinostat—Decreased appetite—Dactinomycin—skin cancer	0.000799	0.00242	CcSEcCtD
Vorinostat—Fatigue—Dactinomycin—skin cancer	0.000793	0.0024	CcSEcCtD
Vorinostat—Anorexia—Temozolomide—skin cancer	0.000793	0.0024	CcSEcCtD
Vorinostat—Body temperature increased—Bleomycin—skin cancer	0.000779	0.00236	CcSEcCtD
Vorinostat—Oedema peripheral—Docetaxel—skin cancer	0.000767	0.00232	CcSEcCtD
Vorinostat—Infection—Fluorouracil—skin cancer	0.000761	0.0023	CcSEcCtD
Vorinostat—Thrombocytopenia—Fluorouracil—skin cancer	0.00075	0.00227	CcSEcCtD
Vorinostat—Anorexia—Fluorouracil—skin cancer	0.00073	0.00221	CcSEcCtD
Vorinostat—Body temperature increased—Dactinomycin—skin cancer	0.000727	0.0022	CcSEcCtD
Vorinostat—Decreased appetite—Temozolomide—skin cancer	0.000723	0.00219	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Temozolomide—skin cancer	0.000718	0.00217	CcSEcCtD
Vorinostat—Fatigue—Temozolomide—skin cancer	0.000717	0.00217	CcSEcCtD
Vorinostat—Constipation—Temozolomide—skin cancer	0.000711	0.00215	CcSEcCtD
Vorinostat—Asthenia—Bleomycin—skin cancer	0.000707	0.00214	CcSEcCtD
Vorinostat—Chills—Docetaxel—skin cancer	0.000698	0.00211	CcSEcCtD
Vorinostat—Pruritus—Bleomycin—skin cancer	0.000697	0.00211	CcSEcCtD
Vorinostat—Alopecia—Docetaxel—skin cancer	0.000688	0.00208	CcSEcCtD
Vorinostat—Decreased appetite—Fluorouracil—skin cancer	0.000666	0.00202	CcSEcCtD
Vorinostat—Dysgeusia—Docetaxel—skin cancer	0.000663	0.00201	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000661	0.002	CcSEcCtD
Vorinostat—Asthenia—Dactinomycin—skin cancer	0.00066	0.002	CcSEcCtD
Vorinostat—Body temperature increased—Temozolomide—skin cancer	0.000657	0.00199	CcSEcCtD
Vorinostat—Muscle spasms—Docetaxel—skin cancer	0.000651	0.00197	CcSEcCtD
Vorinostat—Diarrhoea—Dactinomycin—skin cancer	0.000629	0.0019	CcSEcCtD
Vorinostat—Vomiting—Bleomycin—skin cancer	0.000627	0.0019	CcSEcCtD
Vorinostat—Anaemia—Docetaxel—skin cancer	0.000626	0.0019	CcSEcCtD
Vorinostat—Syncope—Docetaxel—skin cancer	0.000608	0.00184	CcSEcCtD
Vorinostat—Leukopenia—Docetaxel—skin cancer	0.000606	0.00184	CcSEcCtD
Vorinostat—Body temperature increased—Fluorouracil—skin cancer	0.000606	0.00183	CcSEcCtD
Vorinostat—Asthenia—Temozolomide—skin cancer	0.000597	0.00181	CcSEcCtD
Vorinostat—Loss of consciousness—Docetaxel—skin cancer	0.000595	0.0018	CcSEcCtD
Vorinostat—Cough—Docetaxel—skin cancer	0.000591	0.00179	CcSEcCtD
Vorinostat—Pruritus—Temozolomide—skin cancer	0.000588	0.00178	CcSEcCtD
Vorinostat—Nausea—Bleomycin—skin cancer	0.000586	0.00177	CcSEcCtD
Vorinostat—Vomiting—Dactinomycin—skin cancer	0.000585	0.00177	CcSEcCtD
Vorinostat—Chest pain—Docetaxel—skin cancer	0.000577	0.00175	CcSEcCtD
Vorinostat—Diarrhoea—Temozolomide—skin cancer	0.000569	0.00172	CcSEcCtD
Vorinostat—Dry mouth—Docetaxel—skin cancer	0.000564	0.00171	CcSEcCtD
Vorinostat—Dizziness—Temozolomide—skin cancer	0.00055	0.00166	CcSEcCtD
Vorinostat—Infection—Docetaxel—skin cancer	0.000549	0.00166	CcSEcCtD
Vorinostat—Nausea—Dactinomycin—skin cancer	0.000546	0.00165	CcSEcCtD
Vorinostat—Shock—Docetaxel—skin cancer	0.000544	0.00165	CcSEcCtD
Vorinostat—Pruritus—Fluorouracil—skin cancer	0.000542	0.00164	CcSEcCtD
Vorinostat—Thrombocytopenia—Docetaxel—skin cancer	0.000541	0.00164	CcSEcCtD
Vorinostat—Vomiting—Temozolomide—skin cancer	0.000529	0.0016	CcSEcCtD
Vorinostat—Anorexia—Docetaxel—skin cancer	0.000527	0.0016	CcSEcCtD
Vorinostat—Diarrhoea—Fluorouracil—skin cancer	0.000524	0.00159	CcSEcCtD
Vorinostat—Headache—Temozolomide—skin cancer	0.000521	0.00158	CcSEcCtD
Vorinostat—Dizziness—Fluorouracil—skin cancer	0.000507	0.00153	CcSEcCtD
Vorinostat—Nausea—Temozolomide—skin cancer	0.000494	0.0015	CcSEcCtD
Vorinostat—Vomiting—Fluorouracil—skin cancer	0.000487	0.00147	CcSEcCtD
Vorinostat—Decreased appetite—Docetaxel—skin cancer	0.000481	0.00146	CcSEcCtD
Vorinostat—Headache—Fluorouracil—skin cancer	0.00048	0.00145	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Docetaxel—skin cancer	0.000477	0.00145	CcSEcCtD
Vorinostat—Fatigue—Docetaxel—skin cancer	0.000477	0.00144	CcSEcCtD
Vorinostat—Constipation—Docetaxel—skin cancer	0.000473	0.00143	CcSEcCtD
Vorinostat—Nausea—Fluorouracil—skin cancer	0.000455	0.00138	CcSEcCtD
Vorinostat—Body temperature increased—Docetaxel—skin cancer	0.000437	0.00132	CcSEcCtD
Vorinostat—Asthenia—Docetaxel—skin cancer	0.000397	0.0012	CcSEcCtD
Vorinostat—Pruritus—Docetaxel—skin cancer	0.000391	0.00118	CcSEcCtD
Vorinostat—Diarrhoea—Docetaxel—skin cancer	0.000378	0.00115	CcSEcCtD
Vorinostat—Dizziness—Docetaxel—skin cancer	0.000366	0.00111	CcSEcCtD
Vorinostat—Vomiting—Docetaxel—skin cancer	0.000352	0.00106	CcSEcCtD
Vorinostat—Headache—Docetaxel—skin cancer	0.000346	0.00105	CcSEcCtD
Vorinostat—Nausea—Docetaxel—skin cancer	0.000328	0.000994	CcSEcCtD
Vorinostat—HDAC3—Metabolism—ENO2—skin cancer	0.000264	0.000783	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SHH—skin cancer	0.000262	0.000779	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PTGER4—skin cancer	0.000262	0.000779	CbGpPWpGaD
Vorinostat—HDAC6—Disease—ERCC2—skin cancer	0.000261	0.000774	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—RASA1—skin cancer	0.000261	0.000774	CbGpPWpGaD
Vorinostat—NCOR1—Circadian rythm related genes—TP53—skin cancer	0.000259	0.00077	CbGpPWpGaD
Vorinostat—HDAC3—Circadian rythm related genes—IL6—skin cancer	0.000258	0.000767	CbGpPWpGaD
Vorinostat—HDAC3—Disease—FOXO4—skin cancer	0.000257	0.000762	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—FOXO4—skin cancer	0.000256	0.000761	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—IL6—skin cancer	0.000256	0.000758	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—CDK4—skin cancer	0.000251	0.000744	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TERT—skin cancer	0.00025	0.000743	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SMO—skin cancer	0.000249	0.000738	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PTCH1—skin cancer	0.000249	0.000738	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SHH—skin cancer	0.000246	0.000729	CbGpPWpGaD
Vorinostat—HDAC6—Disease—TERT—skin cancer	0.000245	0.000726	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—RASA1—skin cancer	0.000244	0.000724	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—GLI2—skin cancer	0.000243	0.000721	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—ENO2—skin cancer	0.000242	0.000719	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PTGER4—skin cancer	0.000242	0.000719	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—KRAS—skin cancer	0.000239	0.000711	CbGpPWpGaD
Vorinostat—NCOR1—Circadian rythm related genes—IL6—skin cancer	0.000237	0.000705	CbGpPWpGaD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—IL6—skin cancer	0.000237	0.000703	CbGpPWpGaD
Vorinostat—NCOR1—Disease—FOXO4—skin cancer	0.000236	0.0007	CbGpPWpGaD
Vorinostat—HDAC1—Disease—SHH—skin cancer	0.000236	0.0007	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ENO2—skin cancer	0.000236	0.0007	CbGpPWpGaD
Vorinostat—HDAC4—Disease—ERCC2—skin cancer	0.000236	0.0007	CbGpPWpGaD
Vorinostat—HDAC2—Cell Cycle—TP53—skin cancer	0.000234	0.000696	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SMO—skin cancer	0.000233	0.000691	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PTCH1—skin cancer	0.000233	0.000691	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—FOXO4—skin cancer	0.000232	0.000688	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MC1R—skin cancer	0.000232	0.000688	CbGpPWpGaD
Vorinostat—HDAC11—Disease—BRAF—skin cancer	0.000231	0.000686	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—GLI1—skin cancer	0.000229	0.000678	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PTGER4—skin cancer	0.000227	0.000672	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—CDK4—skin cancer	0.000224	0.000665	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CSPG4—skin cancer	0.000224	0.000664	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NOTCH—TP53—skin cancer	0.000222	0.00066	CbGpPWpGaD
Vorinostat—HDAC4—Disease—TERT—skin cancer	0.000221	0.000656	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SHH—skin cancer	0.000221	0.000654	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RASA1—skin cancer	0.000219	0.00065	CbGpPWpGaD
Vorinostat—HDAC8—Disease—ERCC2—skin cancer	0.000218	0.000646	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SUFU—skin cancer	0.000217	0.000643	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—FOXO4—skin cancer	0.000214	0.000635	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—BRAF—skin cancer	0.000214	0.000634	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—ERCC2—skin cancer	0.000213	0.000632	CbGpPWpGaD
Vorinostat—HDAC1—Circadian rythm related genes—TP53—skin cancer	0.000211	0.000627	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTCH1—skin cancer	0.000209	0.00062	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SMO—skin cancer	0.000209	0.00062	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—NRAS—skin cancer	0.000208	0.000619	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTCH2—skin cancer	0.000207	0.000613	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000206	0.000612	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TERT—skin cancer	0.000204	0.000606	CbGpPWpGaD
Vorinostat—HDAC8—Disease—TERT—skin cancer	0.000204	0.000606	CbGpPWpGaD
Vorinostat—HDAC9—Disease—ERCC2—skin cancer	0.000204	0.000604	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—HRAS—skin cancer	0.000204	0.000604	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTGER4—skin cancer	0.000204	0.000604	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SHH—skin cancer	0.000203	0.000601	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—RASA1—skin cancer	0.000201	0.000598	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—FOXO4—skin cancer	0.0002	0.000594	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—IL6—skin cancer	0.000195	0.000578	CbGpPWpGaD
Vorinostat—HDAC6—Disease—BRAF—skin cancer	0.000194	0.000575	CbGpPWpGaD
Vorinostat—HDAC1—Circadian rythm related genes—IL6—skin cancer	0.000194	0.000574	CbGpPWpGaD
Vorinostat—HDAC1—Disease—FOXO4—skin cancer	0.000192	0.000571	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SMO—skin cancer	0.000192	0.00057	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTCH1—skin cancer	0.000192	0.00057	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—CDKN2A—skin cancer	0.000192	0.000569	CbGpPWpGaD
Vorinostat—HDAC9—Disease—TERT—skin cancer	0.000191	0.000567	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.00019	0.000563	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTGER4—skin cancer	0.000187	0.000555	CbGpPWpGaD
Vorinostat—HDAC11—Disease—PTGS2—skin cancer	0.000187	0.000554	CbGpPWpGaD
Vorinostat—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—skin cancer	0.000186	0.000553	CbGpPWpGaD
Vorinostat—HDAC3—Disease—ERCC2—skin cancer	0.000183	0.000543	CbGpPWpGaD
Vorinostat—HDAC2—Direct p53 effectors—TP53—skin cancer	0.000182	0.00054	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—ERCC2—skin cancer	0.000181	0.000537	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—FOXO4—skin cancer	0.00018	0.000534	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—NRAS—skin cancer	0.00018	0.000533	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—KRAS—skin cancer	0.000179	0.000532	CbGpPWpGaD
Vorinostat—HDAC4—Disease—BRAF—skin cancer	0.000175	0.00052	CbGpPWpGaD
Vorinostat—HDAC3—Disease—TERT—skin cancer	0.000171	0.000509	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—CDKN2A—skin cancer	0.000171	0.000508	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TERT—skin cancer	0.000171	0.000508	CbGpPWpGaD
Vorinostat—NCOR1—Disease—ERCC2—skin cancer	0.000168	0.000499	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—FOXO4—skin cancer	0.000165	0.00049	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SHH—skin cancer	0.000165	0.00049	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—NRAS—skin cancer	0.000165	0.00049	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RASA1—skin cancer	0.000164	0.000487	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—BRAF—skin cancer	0.000162	0.00048	CbGpPWpGaD
Vorinostat—HDAC8—Disease—BRAF—skin cancer	0.000162	0.00048	CbGpPWpGaD
Vorinostat—NCOR1—Disease—TERT—skin cancer	0.000158	0.000468	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GLI2—skin cancer	0.000157	0.000465	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SMO—skin cancer	0.000157	0.000465	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTCH1—skin cancer	0.000157	0.000465	CbGpPWpGaD
Vorinostat—HDAC6—Disease—PTGS2—skin cancer	0.000156	0.000464	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TERT—skin cancer	0.000155	0.00046	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—KRAS—skin cancer	0.000155	0.000459	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—ERCC2—skin cancer	0.000153	0.000455	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—HRAS—skin cancer	0.000152	0.000453	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTGER4—skin cancer	0.000152	0.000452	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SHH—skin cancer	0.000152	0.000451	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ENO2—skin cancer	0.000152	0.000451	CbGpPWpGaD
Vorinostat—HDAC8—Cell Cycle—TP53—skin cancer	0.000151	0.000449	CbGpPWpGaD
Vorinostat—HDAC9—Disease—BRAF—skin cancer	0.000151	0.000449	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MC1R—skin cancer	0.000149	0.000443	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—ERCC2—skin cancer	0.000148	0.000438	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GLI1—skin cancer	0.000147	0.000437	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—IL6—skin cancer	0.000146	0.000433	CbGpPWpGaD
Vorinostat—HDAC11—Disease—NRAS—skin cancer	0.000145	0.000431	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TERT—skin cancer	0.000143	0.000424	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—KRAS—skin cancer	0.000142	0.000422	CbGpPWpGaD
Vorinostat—HDAC4—Disease—PTGS2—skin cancer	0.000141	0.00042	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—ERCC2—skin cancer	0.000141	0.000418	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SUFU—skin cancer	0.00014	0.000414	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ERCC2—skin cancer	0.000137	0.000407	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—TP53—skin cancer	0.000136	0.000404	CbGpPWpGaD
Vorinostat—HDAC3—Disease—BRAF—skin cancer	0.000136	0.000403	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—BRAF—skin cancer	0.000136	0.000402	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FOXO4—skin cancer	0.000135	0.0004	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—NRAS—skin cancer	0.000134	0.000399	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TERT—skin cancer	0.000134	0.000397	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—NRAS—skin cancer	0.000132	0.000392	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—HRAS—skin cancer	0.000131	0.00039	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PTGS2—skin cancer	0.000131	0.000387	CbGpPWpGaD
Vorinostat—HDAC1—Disease—TERT—skin cancer	0.000128	0.000381	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—IL6—skin cancer	0.000126	0.000373	CbGpPWpGaD
Vorinostat—HDAC11—Disease—KRAS—skin cancer	0.000125	0.000371	CbGpPWpGaD
Vorinostat—NCOR1—Disease—BRAF—skin cancer	0.000125	0.00037	CbGpPWpGaD
Vorinostat—HDAC2—Circadian rythm related genes—IL6—skin cancer	0.000125	0.00037	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FOXO4—skin cancer	0.000124	0.000368	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—BRAF—skin cancer	0.000123	0.000364	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PTGS2—skin cancer	0.000122	0.000362	CbGpPWpGaD
Vorinostat—HDAC6—Disease—NRAS—skin cancer	0.000122	0.000361	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—HRAS—skin cancer	0.000121	0.000359	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TERT—skin cancer	0.00012	0.000356	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—IL6—skin cancer	0.000116	0.000343	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—KRAS—skin cancer	0.000116	0.000343	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—KRAS—skin cancer	0.000114	0.000337	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—BRAF—skin cancer	0.000113	0.000336	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TERT—skin cancer	0.00011	0.000327	CbGpPWpGaD
Vorinostat—HDAC4—Disease—NRAS—skin cancer	0.00011	0.000327	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PTGS2—skin cancer	0.00011	0.000326	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SHH—skin cancer	0.000106	0.000316	CbGpPWpGaD
Vorinostat—HDAC11—Disease—HRAS—skin cancer	0.000106	0.000315	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—BRAF—skin cancer	0.000106	0.000314	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RASA1—skin cancer	0.000106	0.000314	CbGpPWpGaD
Vorinostat—HDAC6—Disease—KRAS—skin cancer	0.000105	0.000311	CbGpPWpGaD
Vorinostat—HDAC1—Disease—BRAF—skin cancer	0.000102	0.000302	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—NRAS—skin cancer	0.000102	0.000302	CbGpPWpGaD
Vorinostat—HDAC11—Disease—IL6—skin cancer	0.000102	0.000302	CbGpPWpGaD
Vorinostat—HDAC8—Disease—NRAS—skin cancer	0.000102	0.000301	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—skin cancer	0.000101	0.0003	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTCH1—skin cancer	0.000101	0.0003	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SMO—skin cancer	0.000101	0.0003	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PTGS2—skin cancer	0.000101	0.000299	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—HRAS—skin cancer	9.83e-05	0.000292	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTGER4—skin cancer	9.82e-05	0.000292	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—HRAS—skin cancer	9.66e-05	0.000287	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—skin cancer	9.53e-05	0.000283	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—ERCC2—skin cancer	9.51e-05	0.000282	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—BRAF—skin cancer	9.51e-05	0.000282	CbGpPWpGaD
Vorinostat—HDAC9—Disease—NRAS—skin cancer	9.5e-05	0.000282	CbGpPWpGaD
Vorinostat—HDAC4—Disease—KRAS—skin cancer	9.47e-05	0.000281	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—IL6—skin cancer	9.4e-05	0.000279	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTGS2—skin cancer	9.19e-05	0.000273	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TERT—skin cancer	9e-05	0.000267	CbGpPWpGaD
Vorinostat—HDAC6—Disease—HRAS—skin cancer	8.9e-05	0.000264	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERCC2—skin cancer	8.83e-05	0.000262	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—KRAS—skin cancer	8.75e-05	0.00026	CbGpPWpGaD
Vorinostat—HDAC8—Disease—KRAS—skin cancer	8.74e-05	0.000259	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—BRAF—skin cancer	8.74e-05	0.000259	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FOXO4—skin cancer	8.68e-05	0.000258	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NRAS—skin cancer	8.53e-05	0.000253	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NRAS—skin cancer	8.52e-05	0.000253	CbGpPWpGaD
Vorinostat—HDAC6—Disease—IL6—skin cancer	8.52e-05	0.000253	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NRAS—skin cancer	8.51e-05	0.000253	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTGS2—skin cancer	8.44e-05	0.000251	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TERT—skin cancer	8.28e-05	0.000246	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTGS2—skin cancer	8.22e-05	0.000244	CbGpPWpGaD
Vorinostat—HDAC9—Disease—KRAS—skin cancer	8.18e-05	0.000243	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HRAS—skin cancer	8.05e-05	0.000239	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NRAS—skin cancer	7.84e-05	0.000233	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—skin cancer	7.78e-05	0.000231	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NRAS—skin cancer	7.71e-05	0.000229	CbGpPWpGaD
Vorinostat—HDAC4—Disease—IL6—skin cancer	7.71e-05	0.000229	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—HRAS—skin cancer	7.44e-05	0.000221	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HRAS—skin cancer	7.43e-05	0.000221	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KRAS—skin cancer	7.35e-05	0.000218	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KRAS—skin cancer	7.34e-05	0.000218	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—KRAS—skin cancer	7.32e-05	0.000217	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—BRAF—skin cancer	7.12e-05	0.000211	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL6—skin cancer	7.12e-05	0.000211	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NRAS—skin cancer	7.11e-05	0.000211	CbGpPWpGaD
Vorinostat—HDAC8—Disease—IL6—skin cancer	7.11e-05	0.000211	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HRAS—skin cancer	6.95e-05	0.000206	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—skin cancer	6.75e-05	0.0002	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NRAS—skin cancer	6.65e-05	0.000197	CbGpPWpGaD
Vorinostat—HDAC9—Disease—IL6—skin cancer	6.65e-05	0.000197	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—skin cancer	6.63e-05	0.000197	CbGpPWpGaD
Vorinostat—HDAC2—Disease—BRAF—skin cancer	6.56e-05	0.000195	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—skin cancer	6.52e-05	0.000193	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—skin cancer	6.51e-05	0.000193	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NRAS—skin cancer	6.39e-05	0.00019	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HRAS—skin cancer	6.24e-05	0.000185	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—HRAS—skin cancer	6.23e-05	0.000185	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—HRAS—skin cancer	6.23e-05	0.000185	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—skin cancer	6.12e-05	0.000182	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NRAS—skin cancer	5.98e-05	0.000177	CbGpPWpGaD
Vorinostat—HDAC3—Disease—IL6—skin cancer	5.98e-05	0.000177	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL6—skin cancer	5.97e-05	0.000177	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—skin cancer	5.9e-05	0.000175	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TERT—skin cancer	5.8e-05	0.000172	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HRAS—skin cancer	5.74e-05	0.00017	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—skin cancer	5.73e-05	0.00017	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—HRAS—skin cancer	5.64e-05	0.000167	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—skin cancer	5.5e-05	0.000163	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NRAS—skin cancer	5.49e-05	0.000163	CbGpPWpGaD
Vorinostat—NCOR1—Disease—IL6—skin cancer	5.49e-05	0.000163	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—skin cancer	5.44e-05	0.000161	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL6—skin cancer	5.4e-05	0.00016	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—skin cancer	5.29e-05	0.000157	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HRAS—skin cancer	5.2e-05	0.000154	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—skin cancer	5.14e-05	0.000153	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—skin cancer	5.09e-05	0.000151	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL6—skin cancer	4.98e-05	0.000148	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HRAS—skin cancer	4.87e-05	0.000144	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—skin cancer	4.73e-05	0.00014	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HRAS—skin cancer	4.68e-05	0.000139	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL6—skin cancer	4.66e-05	0.000138	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—BRAF—skin cancer	4.59e-05	0.000136	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—skin cancer	4.57e-05	0.000136	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NRAS—skin cancer	4.48e-05	0.000133	CbGpPWpGaD
Vorinostat—HDAC1—Disease—IL6—skin cancer	4.48e-05	0.000133	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HRAS—skin cancer	4.37e-05	0.00013	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—skin cancer	4.2e-05	0.000125	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL6—skin cancer	4.18e-05	0.000124	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NRAS—skin cancer	4.12e-05	0.000122	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HRAS—skin cancer	4.02e-05	0.000119	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—skin cancer	3.85e-05	0.000114	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL6—skin cancer	3.85e-05	0.000114	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—skin cancer	3.55e-05	0.000105	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—skin cancer	3.42e-05	0.000102	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HRAS—skin cancer	3.28e-05	9.72e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6—skin cancer	3.13e-05	9.3e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HRAS—skin cancer	3.01e-05	8.94e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NRAS—skin cancer	2.88e-05	8.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6—skin cancer	2.88e-05	8.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—skin cancer	2.48e-05	7.37e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—skin cancer	2.21e-05	6.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HRAS—skin cancer	2.11e-05	6.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6—skin cancer	2.02e-05	5.99e-05	CbGpPWpGaD
